RNA-dependent RNA polymerase of SARS-CoV-2 as a therapeutic target

被引：65
|
作者：
Wang, Yanyan [1 ]
Anirudhan, Varada [2 ]
Du, Ruikun [1 ,3 ,4 ]
Cui, Qinghua [1 ,3 ,4 ]
Rong, Lijun [2 ]
机构：
[1] Shandong Univ Tradit Chinese Med, Coll Pharm, Jinan 250355, Shandong, Peoples R China
[2] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60612 USA
[3] Shandong Prov Collaborat Innovat Ctr Antiviral Tr, Jinan, Peoples R China
[4] Shandong Univ Tradit Chinese Med, Qingdao Acad Chinese Med Sci, Qingdao, Peoples R China
来源：
JOURNAL OF MEDICAL VIROLOGY | 2021年 / 93卷 / 01期
关键词：
coronavirus; COVID-19; drug target; RdRp; SARS-CoV-2; NUCLEOSIDE/NUCLEOTIDE ANALOG INHIBITORS; RESPIRATORY SYNDROME CORONAVIRUS; DE-NOVO INITIATION; SARS-CORONAVIRUS; INFLUENZA-A; EBOLA-VIRUS; ZIKA VIRUS; IN-VITRO; NUCLEOSIDE ANALOGS; INTERFERON-BETA;
D O I：
10.1002/jmv.26264
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The global pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), named coronavirus disease 2019, has infected more than 8.9 million people worldwide. This calls for urgent effective therapeutic measures. RNA-dependent RNA polymerase (RdRp) activity in viral transcription and replication has been recognized as an attractive target to design novel antiviral strategies. Although SARS-CoV-2 shares less genetic similarity with SARS-CoV (similar to 79%) and Middle East respiratory syndrome coronavirus (similar to 50%), the respective RdRps of the three coronaviruses are highly conserved, suggesting that RdRp is a good broad-spectrum antiviral target for coronaviruses. In this review, we discuss the antiviral potential of RdRp inhibitors (mainly nucleoside analogs) with an aim to provide a comprehensive account of drug discovery on SARS-CoV-2.
引用
收藏
页码：300 / 310
页数：11
相关论文
共 50 条
  • [31] Modeling the Binding Mechanism of Remdesivir, Favilavir, and Ribavirin to SARS-CoV-2 RNA-Dependent RNA Polymerase
    Bylehn, Fabian
    Menendez, Cintia A.
    Perez-Lemus, Gustavo R.
    Alvarado, Walter
    de Pablo, Juan J.
    [J]. ACS CENTRAL SCIENCE, 2021, 7 (01) : 164 - 174
  • [32] Novel sofosbuvir derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective
    Abdulwahed Alrehaily
    Abdo A. Elfiky
    Ibrahim M. Ibrahim
    Mohamed N. Ibrahim
    Amr Sonousi
    [J]. Scientific Reports, 13
  • [33] Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective
    Amr Sonousi
    Hanan A. Mahran
    Ibrahim M. Ibrahim
    Mohamed N. Ibrahim
    Abdo A. Elfiky
    Wael M. Elshemey
    [J]. Pharmacological Reports, 2021, 73 : 1754 - 1764
  • [34] Potential RNA-dependent RNA polymerase (RdRp) inhibitors as prospective drug candidates for SARS-CoV-2
    Bekheit, Mohamed S.
    Panda, Siva S.
    Girgis, Adel S.
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 252
  • [35] Novel sofosbuvir derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective
    Alrehaily, Abdulwahed
    Elfiky, Abdo A.
    Ibrahim, Ibrahim M.
    Ibrahim, Mohamed N.
    Sonousi, Amr
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [36] Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms
    Stevens, Laura J.
    Pruijssers, Andrea J.
    Lee, Hery W.
    Gordon, Calvin J.
    Tchesnokov, Egor P.
    Gribble, Jennifer
    George, Amelia S.
    Hughes, Tia M.
    Lu, Xiaotao
    Li, Jiani
    Perry, Jason K.
    Porter, Danielle P.
    Cihlar, Tomas
    Sheahan, Timothy P.
    Baric, Ralph S.
    Gotte, Matthias
    Denison, Mark R.
    [J]. SCIENCE TRANSLATIONAL MEDICINE, 2022, 14 (656)
  • [37] Non-Nucleotide RNA-Dependent RNA Polymerase Inhibitor That Blocks SARS-CoV-2 Replication
    Dejmek, Milan
    Konkol'ova, Eva
    Eyer, Ludek
    Strakova, Petra
    Svoboda, Pavel
    Sala, Michal
    Krejcova, Katerina
    Ruzek, Daniel
    Boura, Evzen
    Nencka, Radim
    [J]. VIRUSES-BASEL, 2021, 13 (08):
  • [38] Novel adenosine derivatives against SARS-CoV-2 RNA-dependent RNA polymerase: an in silico perspective
    Sonousi, Amr
    Mahran, Hanan A.
    Ibrahim, Ibrahim M.
    Ibrahim, Mohamed N.
    Elfiky, Abdo A.
    Elshemey, Wael M.
    [J]. PHARMACOLOGICAL REPORTS, 2021, 73 (06) : 1754 - 1764
  • [39] Impact of Remdesivir Incorporation along the Primer Strand on SARS-CoV-2 RNA-Dependent RNA Polymerase
    Naseem-Khan, Sehr
    Berger, Madison B.
    Leddin, Emmett M.
    Maghsoud, Yazdan
    Cisneros, G. Andres
    [J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2022, 62 (10) : 2456 - 2465
  • [40] Structural Basis of the Potential Binding Mechanism of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase
    Zhang, Leili
    Zhou, Ruhong
    [J]. JOURNAL OF PHYSICAL CHEMISTRY B, 2020, 124 (32): : 6955 - 6962
12345